Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,257,751
-
Share change
-
+437,762
-
Total reported value
-
$15,005,952
-
Price per share
-
$11.93
-
Number of holders
-
29
-
Value change
-
+$4,350,610
-
Number of buys
-
23
-
Number of sells
-
10
Institutional Holders of GYRE THERAPEUTICS, INC. - COM (GYRE) as of Q2 2024
As of 30 Jun 2024,
GYRE THERAPEUTICS, INC. - COM (GYRE) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,257,751 shares.
The largest 10 holders included
BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, STATE STREET CORP, NORTHERN TRUST CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, WINTON GROUP Ltd, Bank of New York Mellon Corp, RENAISSANCE TECHNOLOGIES LLC, and MARSHALL WACE, LLP.
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.